Drug-susceptible TB: TB treatment strategy has potential to drastically slash therapy duration (TRUNCATE-TB trial)

SEATTLE, February 22, 2023 -- An 8-week tuberculosis (TB) treatment strategy where additional therapy is reserved only for persistent disease or at relapse led to less overall treatment and similar clinical outcomes compared with the standard 6-month approach, an open-label randomized study showed.